Search for: "PFIZER" Results 2821 - 2840 of 4,635
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 Jan 2011, 6:44 am by Mark Zamora
He said attorneys will have to take depositions from numerous Pfizer employees, mostly at the company's headquarters in New York City.To read more, go here:  Link [read post]
5 Jan 2011, 1:34 am by Kelly
General AUTM’s 2010 Better World Report highlights (PatentlyBIOtech) Drug R&D advocate named Kenyan ambassador to UN Geneva (IP Watch) US: Patent eligibility and In re Grams (Patent Docs) US: Main Hastings files false marking complaint against Pfizer based on products from its animal health division (Patent Docs) US: IDEXX files patent infringement complaint against Abbott Laboratories based on its sale of Architect HIV Ag/Ab Combo assay (Patent Docs) US: Life Technologies files… [read post]
5 Jan 2011, 1:17 am by Kevin LaCroix
  One final note about the Pfizer derivative lawsuit settlement concerns the unusual funding mechanism the settlement implemented. [read post]
3 Jan 2011, 9:15 am
 Going forward, Pfizer pledged to “enact rigorous measures to prevent odor-related issues [read post]
2 Jan 2011, 9:18 pm by Patent Docs
Pfizer, Inc. 2:10-cv-00599; filed December 29, 2010 in the Eastern District of Texas False marking based on Pfizer's marking of thirteen different products from its Animal Health Division with various patents (twenty in total) that have expired. [read post]
31 Dec 2010, 4:06 am by Jon L. Gelman
Related articlesWorkers Compensation and Nanotechnology - The New Frontier (workers-compensation.blogspot.com) Carbon Nanotubes And Nanofibers: NIOSH Seeks Comment On Draft Recommendations, Research Needs (nanotech-now.com) Bio-Tech Worker Awarded $1.37 Million in Suit Against Pfizer [read post]
30 Dec 2010, 4:39 pm by Frank Pasquale
Companies such as GlaxoSmithKline have restructured and slimmed down their research arms but the sector remains troubled, as the departure of Jeff Kindler, Pfizer’s former chief executive, on the grounds of “exhaustion” indicates. [read post]
30 Dec 2010, 1:01 pm by Frank Pasquale
Companies such as GlaxoSmithKline have restructured and slimmed down their research arms but the sector remains troubled, as the departure of Jeff Kindler, Pfizer’s former chief executive, on the grounds of “exhaustion” indicates.The obvious course with something that is not working is to drop it. [read post]
29 Dec 2010, 12:54 pm by Bexis
We hope all our readers had excellent holidays, didn’t get stranded in the snow (here on the US East Coast), and received lots of desired presents due to what the economic stats we’ve seen are saying has been a better than expected retailing season. [read post]
29 Dec 2010, 2:57 am by Marie Louise
Pfizer Ltd (Kluwer Patent Blog) Boniva (Ibandronate) – US: Roche dodges Cobalt invalidity contention in Boniva patent suit (Patent Docs) Boniva (Ibandronate) – US: Hoffman-La Roche files patent infringement suit against Mutual Pharmaceutical Company following Para IV certification filing (Patent Docs) Botox (Botulinum) – EU: General Court confirms declarations of invalidity of BOTOLIST and BOTOCYL filed by Allergan: T-345/08 and T-357-08 (Class 46) Detrol (Tolterodine)… [read post]
28 Dec 2010, 1:42 pm by Neal Fortin
On December 22 2010, the European Courts delivered their most important risk regulation judgment since Pfizer. [read post]
28 Dec 2010, 9:56 am by Neal Fortin
On December 22 2010, the European Courts delivered their most important risk regulation judgment since Pfizer. [read post]
The issue has also received attention in the resolution of various high-profile cases, including a recent Pfizer Inc. settlement of criminal and civil matters with the U.S. [read post]
22 Dec 2010, 9:30 am by Lucas A. Ferrara, Esq.
A list of members is below:   Vesel Ademaj Durst Organization Ramon Cruz Energy Consultant Sarah Currie SAC Marketing Christine Datz-Romero Lower East Side Ecology Center Helena Durst The Durst Organization Stefanie Feldman Waste Management Leonard Formato Boulder Resources Richard Gonzalez Urban Design Lab, at the Earth Institute at Columbia University Lloyd Hicks New Leaf Strategic Consulting Joan Levine … [read post]
21 Dec 2010, 1:28 pm
Pfizer, Warner-Lambert Must Defend RICO Claims for Off-Label Marketing of NeurontinThis posting was written by Mark Engstrom, Editor of CCH RICO Business Disputes Guide.Two consumers who suffered from bipolar disorder could proceed with RICO claims against Pfizer, Inc., and Warner-Lambert Co. [read post]
20 Dec 2010, 6:44 pm by Ronald V. Miller, Jr.
No one wants to open up a bad smelling drug so Pfizer takes a little bad medicine PR. [read post]
19 Dec 2010, 1:30 pm by brettb
  It has also been alleged that Pfizer suppressed a study pointing out these issues – Pfizer has denied this. [read post]